Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CYCN
- Price
- 2.75
- Stock movement down
- -0.17 (-5.78%)
- Company name
- Cyclerion Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 7.45M
- Ent value
- 5.28M
- Price/Sales
- 38.42
- Price/Book
- 0.91
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -36.11%
- 1 year return
- 1.48%
- 3 year return
- -38.11%
- 5 year return
- -49.65%
- 10 year return
- -
Last updated: 2025-05-29
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
CYCN does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 1.55 |
| EV to EBITDA | 1.10 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 38.42 |
| Price to Book | 0.91 |
| EV to Sales | 27.22 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 2.71M |
| EPS (TTM) | -2.09 |
| FCF per share (TTM) | -2.47 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 194.00K |
| Gross profit (TTM) | 194.00K |
| Operating income (TTM) | -5.92M |
| Net income (TTM) | -5.28M |
| EPS (TTM) | -2.09 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -3054.12% |
| Profit margin (TTM) | -2722.16% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.87M |
| Net receivables | 44.00K |
| Total current assets | 3.55M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 8.90M |
| Accounts payable | 304.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 700.00K |
| Total liabilities | 700.00K |
| Shareholder's equity | 8.20M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -6.23M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -6.23M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -64.42% |
| Return on Assets | -59.35% |
| Return on Invested Capital | -64.42% |
| Cash Return on Invested Capital | -76.04% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.88 |
| Daily high | 2.88 |
| Daily low | 2.70 |
| Daily Volume | 23K |
| All-time high | 457.00 |
| 1y analyst estimate | 4.00 |
| Beta | 1.92 |
| EPS (TTM) | -2.09 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CYCN | S&P500 | |
| Current price drop from All-time high | -99.40% | -4.11% |
| Highest price drop | -99.70% | -56.47% |
| Date of highest drop | 26 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -88.17% | -11.06% |
| Avg time to new high | 259 days | 12 days |
| Max time to new high | 1548 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
7.45M
Marketcap category
Small-cap
Description
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Employees
1
Website
Investor relations
-
SEC filings
CEO
Peter M. Hecht
Country
USA
City
Cambridge
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page